SFX by Ex Libris Inc.

Title:	Octreotide-Modified Polymeric Micelles as Potential Carriers for Targeted Docetaxel Delivery to Somatostatin Receptor Overexpressing Tumor Cells
Source:	Pharmaceutical Research [0724-8741] Zhang, Yuan yr:2011

Basic

Full text

Full text available via SpringerLINK Contemporary 1997-Present

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Su, Jian-Chiou C. "A synthetic method for peptide-PEG-lipid conjugates: application of octreotide-PEG-DSPE synthesis." Bioorganic & medicinal chemistry letters 18.16 (2008): 4593-6.
description	2.	Peng, Q. "Synthesis of photoactivatable phospholipidic probes." CHINESE CHEMICAL LETTERS PRELIMINARY CHEMICAL COMMUNICATIONS IN ENGLISH 16.3 (2005): 349-.
description	3.	Seitz, O. "Synthetic peptide conjugates-tailor-made probes for the biology of protein modification and protein processing." Tetrahedron 57.12 (2001): 2247-2277.
description	4.	Niculescu-Duvaz, D. "Long functionalized poly(ethylene glycol)s of defined molecular weight: Synthesis and application in solid-phase synthesis of conjugates." Bioconjugate chemistry 19.4 (2008): 973-981.
description	5.	Wu, J. "A folate receptor-targeted liposomal formulation for paclitaxel." International Journal of Pharmaceutics 316.1 (2006): 148-153.
description	6.	Tulla-Puche, J. "Protection by conformationally restricted mobility: first solid-phase synthesis of triostin A." Chemistry : a European journal 14.15 (2008): 4475-4478.
description	7.	Yoshida, T. "Induction of cancer cell-specific apoptosis by folate-labeled cationic liposomes." Journal of controlled release 111.3 (2006): 325-332.
description	8.	Licciardi, M. "New folate-functionalized biocompatible block copolymer micelles as potential anti-cancer drug delivery systems." Polymer 47.9 (2006): 2946-2955.
description	9.	Dicus, Christopher W. "Synthesis of a heterobifunctional PEG spacer terminated with aminooxy and bromide functionality." Synlett 17 (2006): 2821-2823.
description	10.	Garcia-Martin, F. "Design and Synthesis of FAJANU: a de Novo C2 Symmetric Cyclopeptide Family." Journal of medicinal chemistry 51.11 (2008): 3194-3202.
description	11.	Alvarez-SÃnchez, R. "Studies of chemical selectivity of hapten, reactivity, and skin sensitization potency. 3. Synthesis and studies on the reactivity toward model nucleophiles of the 13C-labeled skin sensitizers, 5-chloro-2-methylisothiazol-3-one (MCI) and 2-methylisothiazol." Chemical research in toxicology 16.5 (2003): 627-636.
description	12.	Zhang, H. "Chemically-selective surface glyco-functionalization of liposomes through Staudinger ligation." Chemical communications 21 (2009): 3032-4.
description	13.	Mackay, D. "A solid-phase competition ELISA for measuring antibody to foot-and-mouth disease virus." Journal of Virological Methods 97.1-2 (2001): 33-48.
description	14.	Cemazar, M. "Microwave-assisted Boc-solid phase peptide synthesis of cyclic cysteine-rich peptides." Journal of peptide science 14.6 (2008): 683-689.
description	15.	Raisch, A. "Single-drug multiligand conjugates: Synthesis and preliminary cytotoxicity evaluation of a paclitaxel-dipeptide "scorpion" molecule." Bioconjugate chemistry 17.3 (2006): 565-570.
description	16.	Tomlinson, I. "Universal polyethylene glycol linkers for attaching receptor ligands to quantum dots." Bioorganic & medicinal chemistry letters 16.24 (2006): 6262-6266.
description	17.	Chattopadhyay, J. "Synthesis of water-soluble PEGylated single-walled carbon nanotubes." Chemistry of materials 18.25 (2006): 5864-5868.
description	18.	Hilgenbrink, Andrew R R. "Folate receptor-mediated drug targeting: From therapeutics to diagnostics." Journal of pharmaceutical sciences 94.10 (2005): 2135-2146.
description	19.	Shmeeda, H. "Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors." Molecular cancer therapeutics 5.4 (2006): 818-824.
description	20.	TERADA, T. "Novel PEG-matrix metalloproteinase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective targeting." Journal of Controlled Release 111.3 (2006): 333-342.